of the ruthenium complexes promising candidates in the search for develop new
chemotherapeutic agents for the treatment of cancer. This study aimed to determine the
cytotoxic, genotoxic and to elucidate the signaling pathway involved in the death cell
process induced by cis-[RuCl (BzCN)(bipy)(dppb)] PF 6 (1) and cis-[RuCl
(BzCN)(bipy)(dppe)] PF 6 (2) in Ehrlich ascites carcinoma (EAC) in vitro. Moreover, we …